Tracking mpox spread and vaccine effectiveness in West Africa
Part of Infections clinical trials.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with mpox in the last 10 days, OR had close contact (within 2 meters for at least 5 minutes) with someone with mpox within the last 14 days.
- You are not hospitalized for mpox (mild cases only).
- You are willing and able to attend study visits for up to two months.
- You can provide consent (for children, a parent or guardian can do this; children 12-17 give their own agreement).
- If you are a contact, you should live, work, or study in a community where mpox vaccination is offered.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.